For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

The data, published in JAMA Psychiatry, add to the growing body of evidence supporting the use of GLP-1 receptor agonists for ...

GLP-1 medications that have helped people lose weight may also help people drink less alcohol, according to new ...

Novo Nordisk’s blockbuster GLP-1 diabetes drug Ozempic led to improvements in some measures of alcohol use disorder in a ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

Yet another study is supporting the notion that the blockbuster GLP-1 drug Ozempic can help problems drinkers curb their ...

Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...

South Africa offers a range of treatment options for those struggling with alcoholism, emphasising both medical and ...

Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...